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Abstract
Objectives To use changes in heart disease mortality rates with age to
investigate the plausibility of attributing women’s lower heart disease
mortality than men to the protective effects of premenopausal sex
hormones.
Design Modelling study of longitudinal mortality data with models
assuming (i) a linear association between mortality rates and age
(absolute mortality) or (ii) a logarithmic association (proportional
mortality). We fitted models to age and sex specific mortality rates in the
census years 1950 to 2000 for three birth cohorts (1916-25, 1926-35,
and 1936-45).
Data sources UK Office for National Statistics and the US National
Center for Health Statistics.
Main outcome measure(s) Fit of models to data for England and Wales
and for the US.
Results For England-Wales data, proportional increases in ischaemic
heart disease mortality fitted the data better than absolute increases
(improvement in deviance statistics: women, 58 logarithmic units; men,
37). We identified a deceleration in male mortality after age 45 years
(decreasing from 30.3% to 5.2% per age-year, P=0.042), although the
corresponding difference in women was non-significant (P=0.43, overall
trend 7.9% per age-year, P<0.001). By contrast, female breast cancer
mortality decelerated significantly after age 45 years (decreasing from
19.3% to 2.6% per age-year, P<0.001). We found similar results in US
data.
Conclusions Proportional age related changes in ischaemic heart
disease mortality, suggesting a loss of reparative reserve, fit longitudinal
mortality data from England, Wales, and the United States better than
absolute age related changes in mortality. Acceleration in male heart
disease mortality at younger ages could explain sex differences rather
than any menopausal changes in women.
Introduction
The relative delay in the onset of ischaemic heart disease in
women compared with men, on a population level, has been
attributed largely to the putative protective effects of the
premenopausal hormonal milieu, but little epidemiological or
clinical evidence supports this.
1 Circulating lipids have been
shown to change levels during the menopausal transition,
2 but
interpretation of these changes is made complex by discrepant
changes in the levels of cholesterol and apolipoprotein.
3
Ischaemic heart disease mortality increases with age, but cross
sectionalanalysesofagespecificmortalityhavenotshownany
sudden proportional acceleration at the age of menopause in
women, either in data from England and Wales,
4 the United
States,
5orJapan.
6Bycontrast,theproportionalincreaseinbreast
cancer mortality with age abruptly decelerates at menopausal
age among women.
1 7
Two issues need resolution with respect to previous
cross-sectionalanalyses.Firstly,itisnotknownwhyagerelated
mortality should be examined on the proportional (or
logarithmic) scale for ischaemic heart disease mortality, rather
than an absolute age related increase in mortality, which
accelerates throughout adult life in both men and women. By
contrast, the accumulation of multiple injuries has been
suggested as a mechanistic explanation for a proportional
increase in cancer related mortality with age.
7 Secondly,
ischaemic heart disease has a long latency period before death,
and in view of changing lifestyles and treatment environments
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RESEARCHover a person’s lifetime, it is difficult to interpret cross sectional
associations between age and mortality.
The dual goal of this analysis was to challenge existing
paradigms regarding causality attribution to menopause as it
relates to the risk of ischaemic heart disease in women, by
providing a mechanistic hypothesis for proportional increases
in mortality, and applying it to longitudinal vital statistics data.
To do this, we aimed to show that a proportional change in
mortality is biologically and numerically meaningful, possibly
representing a constant probability of the failure of tissue
reparative cells across a lifetime.
8 9 Indeed, the length of
telomeres in circulating leucocytes, which can be taken as a
proxyforotherbonemarrowcellsthatreplenishthecirculatory
system, reduces linearly during adult life.
10 Because telomere
length shortens linearly with every cell division, the linear loss
of telomere length over adult life
10 indicates that, on average,
cellsdivideataconstantrateovertime.Lossoftelomerelength
limits a cell’s capacity to replicate.
11 Therefore, regeneration of
bone marrow cells is limited in a linear fashion with increasing
age. This explanation is a generalisation of the cancer specific
process proposed by Pike and colleagues
7 to all senescent
chronic disease, and is based on age related heart disease
mortality among birth cohorts (born 1916-45) in England and
Wales
12 and the United States.
13
Methods
Mortality models as a function of age
Model 1 assumes a linear association between mortality rates
and age (absolute mortality). Indeed, this model is implicit in
the statement of the current hypothesis that the increase in
absoluteheartdiseasemortalityacceleratesatmenopause.Such
a model would suggest that the upward slope of absolute
mortalityversusageisroughlyconstantbeforemenopause,and
wouldchangetoadifferentslopearoundthetimeofmenopause
in women.
Mortality rate=β0+β1×age in years+β2×(time since
menopause in years)
(where β0=intercept, β1=linear slope with respect to
age, and β2=change in slope after menopause; if there
is no change in slope at menopause, β2 estimate=0)
Model 2 assumes a proportional (or logarithmic) association
betweenmortalityandage.Survivalofanorganismresultsfrom
an ongoing repair of tissue injury that is dependent on a pool
of repair mechanisms (for example, regenerative repair cells).
Ageing is thought to be a result of loss of this pool. If the
probability of removal of these reparative cells due to cell
division is constant over time, the reparative reserve is lost at
a constant proportion with age. Using the derivation in web
appendix 1, we obtained the following model:
log(mortalityrate)=β0+β1×ageinyears+β2×(timesince
menopause in years)
(where β0=intercept, β1=linear slope with respect to
age, and β2=change in slope after menopause; if there
is no change in slope at menopause, β2 estimate=0)
Therefore, we can interpret modelling changes in proportional
mortality in model 2, rather than absolute mortality as in model
1, as changes in reparative demands on a decreasing reserve of
repair mechanisms (for example, stem cells).
We used the deviance metric
(loge(likelihood
2
reference/likelihood
2
model)),withthenaivemodelas
the reference, to determine which model made the better fit to
the data. For likelihood calculations to be comparable, we also
specified the residuals from the models in the same
manner—that is, on the absolute mortality rate scale.
Modelling of data from England, Wales, and
the United States
We analysed data abstracted from the United Kingdom Office
for National Statistics 20th century mortality data for England
and Wales,
12 US census and vital statistics databases, and the
US National Center for Health Statistics.
13 We used the age and
sex specific mortality rates for the actual census years 1950 to
2000. We used the methods proposed by Frost
14 to follow the
mortalityofthreedecade-longbirthcohorts(1916-25,1926-35,
and 1936-45). We chose these birth cohorts because they
included women who reached postmenopausal ages within the
20th century, and these cohorts were relatively unaffected by
largescaleimmigrationwavesintotheUnitedStates.Wechose
the same birth cohorts for the England-Wales data for
comparability.
We followed US cohorts in time thus: the census counts and
mortality rates for the 1936-45 cohort corresponded with the
5-14 year age group (cohort mid-age rounded to 10 years) in
the 1950 census and vital statistics reports, and the 15-24 year
age group (cohort mid-age 20 years) in the 1960 reports. We
continued this method up to the 75-84 year age group (cohort
mid-age 80 years) in the 2000 reports. Similarly, we traced the
mortality rates for all three cohorts. We analysed all cause
mortality and disease specific mortality rates for heart disease
(in men and women) and breast cancer (only in women).
We abstracted mortality data for ischaemic heart disease and
breastcancerfortheEngland-Walescohorts,usingInternational
Classification of Diseases codes (table 1⇓). For the US data
source,
13longitudinalmortalityratesoverthefullanalysisperiod
were available for total heart disease rather than for ischaemic
heartdisease.TheNationalCenterforHealthStatisticscollected
breast cancer mortality data only for women older than 25
years.
13 We excluded death rates for individuals older than 85
years because the National Center for Health Statistics placed
these deaths into a single group in these datasets. Therefore, we
couldnotassigntheseindividualstoanyparticulardecadalbirth
cohort. Web appendix 2 shows the full abstracted dataset from
the vital statistics sources used to graph and model the data.
We analysed data separately for men and women. We used the
cohort mid-age as the age variable for plotting and regression
analysis. We regarded rates for women in cohorts when they
aged to 45-54 years (cohort mid-age 50 years) and older to be
postmenopausal.Thevastmajorityofmenopauseoccursduring
the 45-54 year age period. We also compared the different
age-mortality slopes before and after 45 years of age in models
1 and 2, to determine whether the age-mortality trend would
change at menopause in women, and at a similar age in men.
We calculated the longitudinal death rates in the cohorts using
generalised mixed models. For comparability of model fit
between the linear age dependence and the log-linear age
dependence, we calculated the explained variance in the
mortality rate data on the original scale (Gaussian residual
errors).Detailedmodelequationsarepresentedinwebappendix
1. If we saw a secular trend by calendar year, we would model
such a trend as secondary analysis.
To compare the models, we tabulated deviance statistics and
the difference in the Akaike information criterion
15 with the
naive linear model as the reference. We considered a reduction
of at least four logarithmic units in the Akaike information
criterion to be a significant improvement, and a reduction of at
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RESEARCHleast10logarithmicunitstobeahighlysignificantimprovement
inmodelfit(simplifiedfromBurnhamandAnderson’smultiple
level criteria
16).
Modelfittingwasundertakenusingthegeneralisedlinearlatent
and mixed models software implemented in Stata (version 10,
StataCorp, College Station, TX, USA). Web appendix 1 also
describes the sensitivity analysis.
Results
Table 2⇓ shows the census counts of men and women of the
three birth cohorts (1916-25, 1926-35, and 1936-45) for 1950
and 2000, by country. Figure 1⇓ shows the ischaemic heart
diseasemortalityofthethreebirthcohortsinEnglandandWales
as they aged in the 20th century, either on the absolute scale or
the logarithmic scale.
For the England-Wales birth cohorts, all absolute mortality
curvesshowedanupward-bentprofile,whereasthelog-mortality
curvesdidnotshowaprominentupwardbend.Amongwomen,
none of the cohorts showed a substantial upward shift in slope
inthelog-mortalitycurvesduetoischaemicheartdiseasearound
thetimeofmenopause(45-55years),andtherewasalog-linear
increase in mortality throughout all ages. Among men, the
log-linear increase in mortality was strongly blunted after age
45 years in all birth cohorts. For both men and women, we saw
a reduction in the overall mortality of successive birth cohorts
at advanced ages. US data for total heart disease mortality also
showed the same pattern (fig 2⇓).
Figure 3⇓ shows female breast cancer mortality on the absolute
and logarithmic scales in the England-Wales and the US birth
cohorts.Aswithpreviouscrosssectionalanalyses,
1weobserved
a distinct difference in slope gradients before and after age 45
years in the log-mortality rate plots. We did not see any
cohort-wide reductions in breast cancer mortality for later
cohorts,especiallyatyoungages.However,thereisasuggestion
that the log-mortality curves could have flattened in the 1990s
for all cohorts (that is, at different ages for each of the cohorts).
This finding could be a secular phenomenon related to the
adoption of breast cancer screening programmes in the early
1990s.
17-19
Table 3⇓ shows the association of mortality with age by
longitudinal data analysis for the various models and their
goodness of fit. For all cause mortality and heart disease
mortality,thelog-mortalitymodelsfitthedatamuchbetterthan
the absolute mortality models. Interestingly, women showed a
non-significant deceleration in the log-mortality curves after
age 45 years, whereas men showed a significant deceleration
after age 45 years. For breast cancer mortality in women, the
log-mortality model showed the best fit, with a significant
deceleration of age related increase in mortality after age 45
years. We also identified a strong secular trend for reduced
breast cancer mortality after 1990 (fig 3). After adjusting for
birth cohort and age, breast cancer mortality was 25% lower
after1990.Webappendix3showssimilarresultsoftheanalyses
of total heart disease and breast cancer mortality in US data.
Discussion
We have shown that analysis using log-linear mortality rates is
consistentwiththeplausiblebiologicalmechanismofreparative
reserve. By using the most comprehensive and complete
longitudinal mortality dataset available for England and Wales
as well as for the United States, in the 20th century, we have
shown that log-linear models fit the mortality data much better
than a simple linear model.
Comparison with previous findings from
cross sectional analyses
Our longitudinal cohort analysis confirms previously reported
cross sectional age-mortality associations.
4 5 However, our
findings are more convincing than those of previous analyses,
because age trends are best studied by following cohorts of
individuals over their lifetime rather than comparing different
individuals of the same and different ages in a cross section of
the population.
Issues of unaccounted secular trends and cohort effects have
clouded the interpretation of cross sectional mortality analyses,
and are resolved by our longitudinal analysis. Cross sectional
analyses would not have detected our finding that cohorts born
later in the 20th century have lower cardiovascular mortality at
higher ages than cohorts born earlier in the 20th century. In
addition, our analysis showed a secular change in breast cancer
mortality after the 1990s, which could not have been detected
with cross sectional analysis.
We showed that there was no sharp increase in slope or step
increase in ischaemic heart disease mortality among women at
menopausal ages. The mortality steadily increased across all
ages in adult women, whereas the corresponding increase was
blunted at older ages in men. These observations also applied
to three birth cohorts in different countries, presumably with
varyingsecularlifeexperiencesintermsoflifestyle,knowledge
of health risks (such as smoking), and disease and risk factor
treatments. These data strengthen the conclusions of previous
cross sectional analyses.
5 In our longitudinal birth cohort
analyses, the age effect is not confounded by the decreasing
overallheartdiseaseriskofsuccessivebirthcohorts.Therefore,
the flattening of the curves at higher ages in men should be
justifiably considered a biological phenomenon rather than an
artefact of cross sectional analysis.
Potential explanations for age-mortality trends
The steady log-linear increase in age related heart disease
mortality in men and women suggests cumulative effects of
lifelong vascular injury and failure of repair mechanisms.
However,thisinterpretationisbasedonmathematicalderivation
and published biological studies in small samples, and not
measurements in these national cohorts.
Becausebothmenandwomeninourstudyshowedupwardbent
curves on the absolute mortality scale, the upward bend cannot
be interpreted as being attributable to menopause. In fact, men
showed a steeper age-mortality slope than women as young
adults, which flattened into middle age. As previously
suggested,
1theacceleratedriskinmenatyoungeragescompared
with women at the same ages could indicate an accelerated
failure of the reparative reserve in young men, rather than the
relative protection of premenopause hormonal effects in young
women. Because we analysed only vital statistics data (and
thereforecouldnotanalyseindividualcardiovascularriskfactors
or the individual timings of menopause in women), this
biological explanation is speculative. However, our proposed
mechanism is consistent with a study reporting that the rate of
telomere loss per age-year was equal in adult men (0.038
kb/age-year)andwomen(0.036kb/age-year)atallagesbetween
25 and 75 years.
20 But in that study,
20 age adjusted telomere
lengths were substantially shorter, by 0.28 kb, in men than
women.Thisdifferenceisequivalenttothetelomereshortening
process being shifted 7.6 age-years in men, compared with
women.
Although we did not see any proportional acceleration of heart
disease mortality at menopause, the absolute mortality still
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RESEARCHincreases at all ages in women, including the postmenopausal
period. Thus the current concern about cardiovascular disease
among women in the ageing US population is fully justified,
but with the focus on lifetime risk rather than primarily at
menopause.
Pike and colleagues discussed that carcinogenesis, being a
multistage process, would be expected to have a log-linear
age-mortality association, and they showed such an association
for colorectal cancer mortality.
7 From new cell biological
insights,
8-10wegeneralisedthisparadigmtoallchronicsenescent
processes,includingthemultistageaccumulationofcarcinogenic
trauma, as well as vascular damage under the general concept
of the failure of reparative reserve. Our models confirm the
deceleration of breast cancer mortality around the age of
menopause as previously shown.
5 7 This finding is consistent
with our biological model that non-communicable diseases
could represent a failure of the reparative reserve. The cyclical
hyperplasia and hypoplasia of breast tissue (evidence reviewed
by Pike et al
7) before menopause is expected to strain the
reparative reserve for this organ more than after menopause.
The demands on the reparative reserve could vary with age for
different organ systems, and for the two sexes, modulating the
rateofreductioninreparativereserveoverage.Similarly,known
cardiovascular risk factors such as smoking,
hypercholesterolaemia,andhypertensionmightdamagevascular
tissue and therefore increase the demand for repair. This would
consequently alter the rate of loss of reparative reserve. We
recognise that a full explanation of the age association of cause
specific mortality due to chronic senescent conditions would
require modelling these factors. However, the log-linear
mortality-agemodelhadamuchbetterfitthanthesimplelinear
model.
Census and mortality data
A major strength of this analysis is the comprehensive nature
oftheBritishandUScensusandmortalitydata.However,there
are specific caveats. Although we examined ischaemic heart
disease mortality in the British data, cause specific mortality
datawerenotseparatelyavailableforthediseaseintheUSdata
source for periods before 1980.
13 However, the findings were
substantiallysimilarinthetwoanalyses.Ischaemicheartdisease
constitutedmostoftheageadjustedtotalheartdiseasemortality
in the United States for years when the data were separately
available—for example, of total heart mortality in 2000, 75.4%
in men and 69.5% in women were due to ischaemic heart
disease. Thus the US and British data were similarly
interpretable. Total heart disease mortality also includes deaths
due to heart failure, which is a chronic senescent condition
associatedwiththelossofprogenitorcells,
21 22andourbiological
discussion applies to heart failure as well.
Anotherconsiderationisthatthebirthcohortswereopencohorts
due to immigration and emigration. However, individuals who
migrated to the United States as adults in the 1900-20 wave of
immigration would not greatly affect the earliest birth cohort
(1916-25) of this analysis. The recent major immigration wave
of 1980-2000 included mostly young adults and added little to
the population aged 45 years and older,
23 and should not affect
our latest birth cohort. In addition, the US and Britain have
different migration experiences, yet we found similar results
between the two datasets, suggesting that immigration patterns
are unlikely to affect the conclusions and interpretation of our
analysis.
Conclusions
We have shown that each successive birth cohort in England,
Wales, and the United States in 1916-45 had lower total and
heart disease mortality over their lifetimes. Heart disease
mortalityinwomenincreasedexponentiallythroughoutallages,
with no special step increase at menopausal ages. This finding
sharplycontrastswithbreastcancermortalityinwomen,which
decelerated drastically at menopause. The increase in heart
disease mortality due to age in men was greater during early
adulthood than that in women, and the age related increase was
blunted at advanced ages.
Efforts to improve cardiac health in women should focus on
lifetimeriskratherthanriskonlyaftermenopause.Ourproposed
biological model showing that fatal events are a result of a loss
of reparative reserve fitted the mortality data far better than a
modeloflinearagerelatedincreasesinabsolutemortalityrates.
This finding should serve as a point of departure for more
refined models of age related mortality.
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RESEARCHWhat is already known on this topic
Although heart disease mortality increases with age, it is lower in women than in men
It has been suggested that this protective effect is due to female sex hormones, and the protection is therefore lost at
menopause
What this study adds
Heart disease mortality in women increased exponentially with age, with no acceleration at menopause. In men, there
was a rapid increase during young adulthood followed by reduced rates of increase
The early rapid acceleration in male heart disease mortality could explain these sex differences rather than menopausal
changes in women
Efforts to improve cardiac health in women should focus on their lifetime risk rather than only after menopause
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RESEARCHTables
Table 1| International Classification of Diseases (ICD) codes for ischaemic and total heart disease and female breast cancer
Breast cancer (UK and United States) Total heart disease (United States) Ischaemic heart disease (UK)
170 410 to 443 420.0 to 420.2 ICD-6
170 400 to 402, 410 to 443 420.0 to 420.2 ICD-7
174 390 to 398, 402, 404, 410 to 429 410 to 414 ICD-8
174 to 174.9 390 to 398, 402, 404, 410 to 429 410 to 414 ICD-9
C50 I00 to I09, I11, I13, I20 to I51 I20 to I25 ICD-10
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RESEARCHTable 2| Populations of birth cohorts (in thousands) in census years 1950 and 2000
United States England and Wales
Census year Birth cohort Men Women Men Women
11 597 12 162 1673 1681 1950 1916-25
4879 7482 741 1050 2000
10 918 11 181 1346 1390 1950 1925-35
8303 10 088 1100 1198 2000
12 375 11 944 1569 1501 1950 1935-45
11 645 12 629 1429 1455 2000
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RESEARCHTable 3| Ischaemic heart disease mortality and female breast cancer mortality in England-Wales birth cohorts, by sex
Breast cancer (women only) Ischaemic heart disease Model
Women Men
Deviance,
difference in
AIC†
β, P* Deviance,
difference in
AIC†
β, P* Deviance,
difference in
AIC†
β, P*
Reference 2.5, P<0.001 Reference 10.3, P<0.001 Reference 22.4, P<0.001 Linear (overall slope)
−5
−5
4.2%, P<0.001 −58
−58
7.9%, P<0.001 −37
−37
5.8%, P<0.001 Log-linear (overall
slope)
Linear with spline‡
−5
−3
1.4, P<0.001 −19
−17
−4.2, P=0.14 −16
−14
−2.1, P=0.61 Slope before age 45
years
2.1, P<0.001 29.0, P<0.001 48.9, P<0.001 Difference in slope
after age 45 years
Log-linear with spline‡
−31
−29
19.3%, P<0.001 −62
−60
39.3%, P=0.32 −50
−48
30.3%, P=0.014 Slope before age 45
years
−16.7%, P<0.001 −31.6%, P=0.43 −25.1%, P=0.042 Difference in slope
after age 45 years
AIC=Akaike information criterion.
*β= slope or change in slope after age 45 years compared with the slope before age 45 years. P=probability for Wald test of significance of the null hypothesis
that β equals 0. Linear slopes represent increase in deaths per 100 000 per age-year. Log-linear slopes represent percentage increase in mortality per age-year.
†A lower or more negative deviance indicates better model fit. The difference in AIC penalises the deviance metric for the addition of extra parameters in the
interest of model parsimony.
‡Spline models included the variable “age-spline” was equal to 0 if cohort mid-age was under 50 years (that is, younger than the 45-54 year cohort), and equal to
the cohort mid-age for older ages.
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RESEARCHFigures
Fig 1 Ischaemic heart disease mortality in England and Wales by age plotted on absolute scale (top panels) and on
logarithmic scale (bottom panels)
Fig 2 Total heart disease mortality in the United States by age plotted on absolute scale (top panels) and on logarithmic
scale (bottom panels)
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RESEARCHFig 3 Female breast cancer mortality in England and Wales and the United States plotted on absolute scale (top panels)
and on logarithmic scale (bottom panels)
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